Sign inJoin waitlistJoin the waitlist

Sanjay Kulkarni

Surgical Director of Kidney Transplantation · Yale-New Haven Hospital

Credentials: · · · · ·

History

Kidney Transplantation · Yale-New Haven Hospital
Present
New England Donor Services
Present
Center for Living Organ Donors · Yale-New Haven Hospital
Present

Surgery
Yale-New Haven Hospital
2022–Present
Harvard University, School of Public Health
2018
University Hospital Essen
2001–2004
University Hospital Essen
2003–2004
Until 2002
University of Chicago Medical Center
1996–1999
University of Chicago
1998–1999
Medical College of Wisconsin
1991–1995
University of Wisconsin School of Medicine and Public Health
1987–1990
University of Wisconsin
1990
University of Wisconsin
1989–1990

Research

Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells
Circulation · 2013 · 129 citations
Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
American Journal of Transplantation · 2017 · First of 9 authors · 122 citations
Association of Racial Disparities With Access to Kidney Transplant After the Implementation of the New Kidney Allocation System
JAMA Surgery · 2019 · First of 6 authors · 74 citations

Richard Formica
19 papers
Carrie Thiessen
11 papers · 10 as a resident
David Mulligan
9 papers · 2 as a fellow
William Asch
9 papers
AA
Antonios Arvelakis
7 papers
SE
Sukru Emre
7 papers
Peter Yoo
6 papers · 4 as a fellow
DC
David Cronin
5 papers
GT
George Tellides
5 papers
MB
Margaret Bia
5 papers
Michael Schilsky
5 papers
Peter Reese
5 papers · 1 as a fellow

Grants

Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $999.1K · Yale University
2020–2026

Clinical trials

Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
Principal investigator · Withdrawn · Early phase 1
Yale University
2021–2023
Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation
Principal investigator · Completed · Phase 1
Sanjay Kulkarni
2011–2015
Bariatric Surgery for ESRD Patients vs Control
Principal investigator · Terminated
Yale University
2005–2011
Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System
Study director · Completed
Yale University
2014–2016